Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,224,788
+$15,735,900 QoQ
Shares Held
102,200
+804.4% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#120
of 768 holders
Holding Since
Dec 2023
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ING GROEP NV holds $98,513,048 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRLV |
Trulieve Cannabis Corp.
|
2,665,000 | $26,196,950 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $24,650,000 | |
| 3 | ZTS |
Zoetis Inc.
|
276,942 | $19,901,052 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
102,200 | $17,224,788 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
18,800 | $10,186,404 | |
| 6 | VTRS |
Viatris Inc
|
22,283 | $353,854 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,224,788 | 102,200 | Shares | Defined | 2026-08-13 | |
| 2023-12-31 | $1,488,888 | 11,300 | Shares | Defined | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||